Canada Nephrology and Urology Devices Market Outlook to 2025 – Renal Dialysis Equipment
All the vital news, analysis, and commentary curated by our industry experts.
GlobalData’s “Canada Nephrology and Urology Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Canada Nephrology and Urology Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Renal Dialysis Equipment.
The Canada Nephrology and Urology Devices Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2019 company share and distribution share data for Nephrology and Urology Devices Market.
• Global corporate-level profiles of key companies operating within the Canada Nephrology and Urology Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Canada Nephrology and Urology Devices is segmented as follows:
• Renal Dialysis Equipment
Reasons to Buy
Key Reasons to Purchase – The Canada Nephrology and Urology Devices Market report helps you to develop:
• Business strategies by identifying the key market segments poised for strong growth in the future.
• Market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the market.
• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
• Fresenius Medical Care AG & Co KGaA
• Baxter International Inc
• Asahi Kasei Corp
Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 7
2.1 What Is This Report About? 7
2.2 Nephrology and Urology Devices Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 8
3 Nephrology and Urology Devices Market, Canada 10
3.1 Nephrology and Urology Devices Market, Canada, Revenue ($m), 2015-2025 10
3.2 Nephrology and Urology Devices Market, Canada, Revenue ($m), 2015-2025 11
3.3 Nephrology and Urology Devices Market, Canada, Volume (Units), 2015-2025 13
3.4 Nephrology and Urology Devices Market, Canada, Volume (Units), 2015-2025 14
3.5 Nephrology and Urology Devices Market, Canada, Company Share by Revenue ($m), 2019 16
4 Renal Dialysis Equipment Market, Canada 18
4.1 Renal Dialysis Equipment Market, Canada, Revenue Mix ($m), 2019 18
4.2 Renal Dialysis Equipment Market, Canada, Segment Contribution (%), 2019 19
4.3 Renal Dialysis Equipment Market, Canada, Revenue ($m), 2015-2025 20
4.3.1 Dialysis Accessories Market, Canada, Revenue ($m), by Segment, 2015-2025 22
4.3.2 Dialysis Machines Market, Canada, Revenue ($m), by Segment, 2015-2025 25
4.3.3 Vascular Access Devices for Hemodialysis Market, Canada, Revenue ($m), by Segment, 2015-2025 27
4.4 Renal Dialysis Equipment Market, Canada, Volume (Units), 2015-2025 30
4.4.1 Dialysis Accessories Market, Canada, Volume (Units) by Segment, 2015-2025 32
4.4.2 Dialysis Machines Market, Canada, Volume (Units) by Segment, 2015-2025 35
4.4.3 Vascular Access Devices for Hemodialysis Market, Canada, Volume (Units) by Segment, 2015-2025 37
4.5 Renal Dialysis Equipment Market, Canada, Average Price ($), 2015-2025 40
4.6 Renal Dialysis Equipment Market, Canada, Distribution Share by Revenue ($m), 2019 42
4.7 Renal Dialysis Equipment Market, Canada, Company Share by Revenue ($m), 2019 43
5 Overview of Key Companies in Canada, Nephrology and Urology Devices Market 45
5.1 Fresenius Medical Care AG & Co KGaA 45
5.1.1 Company Overview 45
5.2 Baxter International Inc 45
5.2.1 Company Overview 45
5.3 Asahi Kasei Corp 45
5.3.1 Company Overview 45
5.4 Nipro Corp 46
5.4.1 Company Overview 46
5.5 B. Braun Melsungen AG 46
5.5.1 Company Overview 46
5.6 CR Bard Inc 46
5.6.1 Company Overview 46
5.7 Toray Medical Co Ltd 47
5.7.1 Company Overview 47
6 Nephrology and Urology Devices Market Pipeline Products 48
7 Financial Deals Landscape 50
7.1 Equity Offerings 50
7.1.1 Spectral Medical Withdraws Public Offering of Common Shares 50
7.1.2 Imagin Medical Raises USD1.5 Million in Private Placement of Units 51
7.1.3 Kane Biotech Raises USD0.7 Million in Second Tranche of Private Placement of Units 52
7.1.4 Kane Biotech Raises USD1.8 Million in First Tranche Private Placement of Units 53
7.1.5 Aquarius Surgical Technologies Raises USD0.4 Million in First Tranche of Private Placement of Units 55
7.1.6 Aquarius Surgical to Raise up to USD2.3 Million in Private Placement of Units 56
7.1.7 Aquarius Surgical to Raise up to USD2 Million in Private Placement of Units 57
7.1.8 Covalon Technologies Raises USD4.2 Million in Private Placement of Units 58
8 Recent Developments 59
8.1 Corporate Communications 59
8.1.1 Feb 20, 2020: Kane Biotech welcomes renowned Canadian veterinarian, Dr. Jean Gauvin, as Chief Veterinary Officer 59
8.1.2 Jan 06, 2020: CRH Medical appoints Tom Sanders as Vice President of Commercial Development 59
8.1.3 Dec 16, 2019: Jean-Claude Dubacher named Chairman and Chief Executive Officer of B. Braun Medical 60
8.1.4 Nov 19, 2019: Winterlight Labs raises Series A funds to develop AI vocal technology 60
8.1.5 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership 61
8.1.6 Jul 17, 2019: Spectral Medical announces new Chief Financial Officer 61
8.1.7 May 01, 2019: Matinas BioPharma selected to present at the BioNJ Ninth Annual BioPartnering Conference 62
8.1.8 Apr 17, 2019: Imagin Medical welcomes world-renowned Bladder Cancer expert Dr. Ashish M. Kamat to its Scientific Board of Advisors 62
8.1.9 Apr 09, 2019: CRH Medical appoints Dr. Tushar Ramani as new CEO 63
8.2 Financial Announcements 64
8.2.1 Mar 02, 2020: Covalon announces first quarter fiscal 2020 results 64
8.2.2 Dec 24, 2019: Imagin Medical reports fiscal year end 2019 results 65
8.2.3 Dec 13, 2019: Boehringer Ingelheim and Lilly provide update on Jardiance phase III exercise ability studies in chronic heart failure 66
8.2.4 Nov 14, 2019: Kane Biotech announces third quarter 2019 financial results 68
8.2.5 Nov 07, 2019: CRH Medical Corporation announces 2019 third quarter results 69
8.2.6 Nov 05, 2019: Autolus Therapeutics receives FDA Orphan Drug Designation for AUTO1 for treatment of Acute Lymphoblastic Leukemia 69
8.2.7 Aug 28, 2019: Covalon announces third quarter fiscal 2019 results 70
8.2.8 Aug 27, 2019: Imagin Medical reports fiscal 2019 third quarter results 71
8.2.9 Aug 21, 2019: Kane Biotech announces second quarter 2019 financial results 72
8.2.10 Aug 15, 2019: Spectral announces second quarter results 73
8.2.11 Aug 06, 2019: Kane Biotech awarded $3.8 million in non-dilutive government funding 74
8.2.12 Jul 31, 2019: CRH Medical announces 2019 second quarter results 75
8.2.13 Jun 25, 2019: Theralase brain cancer pre-clinical research accepted for publication 75
8.2.14 Jun 11, 2019: Imagin Medical reports fiscal 2019 second quarter results 78
8.2.15 May 28, 2019: Covalon announces second quarter fiscal 2019 results 78
8.2.16 May 22, 2019: Kane Biotech Announces First Quarter 2019 Financial Results, Extension of Loan and Insider Funding 79
8.2.17 May 09, 2019: Spectral announces first quarter results 80
8.2.18 May 01, 2019: CRH Medical announces 2019 first quarter results 81
8.3 Government and Public Interest 81
8.3.1 Oct 07, 2019: Digital kidney sheds light on link between hydration and acute injury 81
8.4 Legal And Regulatory 82
8.4.1 Sep 26, 2019: TSO3 announces receipt of final Court approval for plan of arrangement with Stryker 82
8.5 Other Significant Developments 82
8.5.1 Mar 05, 2020: ADDvise signs a new agreement with Laborie with a total order value of at least MSEK 50 82
8.5.2 Feb 13, 2020: Laborie Medical Technologies closes Clinical Innovations acquisition 82
8.5.3 Jan 27, 2020: Kane Biotech engages Independent Trading Group for market-making services 83
8.5.4 Jan 23, 2020: Imagin Medical finishes 2019 strong and provides insight into 2020 & beyond 83
8.5.5 Nov 26, 2019: Kane Biotech engages Kilmer Lucas for cross-border Investor Relations 84
8.5.6 Nov 26, 2019: Aquarius Surgical Technologies reports increased sales in the first half of 2020 84
8.5.7 Oct 23, 2019: CRH Medical announces new revolving credit facility 85
8.5.8 Oct 17, 2019: Imagin Medical announces Social Media Campaign launch 85
8.5.9 Aug 08, 2019: Spectral Medical provides corporate update 86
8.5.10 Aug 01, 2019: Kane Biotech announces new funding granted from CanExport Program 86
8.5.11 Jul 25, 2019: Covalon CEO provides corporate update 87
8.5.12 Jun 10, 2019: Bactiguard enters Canada 88
8.5.13 Apr 24, 2019: Kane Biotech announces new sales representation by SLA brands 88
8.5.14 Apr 10, 2019: Canadian hospital Trillium Health Partners selects Sectra’s enterprise imaging solution 88
8.6 Product News 89
8.6.1 May 02, 2019: Interface Biologics Poster Presentation at AUA 2019, Chicago, IL 89
8.7 Strategy And Business Planning 90
8.7.1 Nov 07, 2019: Aquarius Surgical Technologies offers unique Equipment Financing through a partnership with Dext Capital 90
9 Appendix 91
9.1 Research Methodology 92
9.1.1 Coverage 92
9.1.2 Secondary Research 92
9.1.3 Primary Research 93
9.1.4 Market Modeling and Forecasting 93
9.1.5 Company Share Analysis 95
9.1.6 Distribution Share Analysis 95
9.1.7 Benchmarking 96
9.2 GlobalData Consulting 96
9.3 Contact Us 97
9.4 Disclaimer 97
Frequently asked questions
Undecided about purchasing this report?Enquire Before Buying
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Business Intelligence & Marketing Manager, SAL Heavy Lift
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
Market Analyst & Management, Liebherr-Werk
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Head of Key Accounts, Saab AB
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Marketing Intelligence Manager, Portugal Foods
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Head of Customer Insight and Research, Standard Chartered
Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.
I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.
I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.
Head of Consumer Sensory Insights, Givaudan
“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.
Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”
Senior Account Manager, TSYS
GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.
I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.
One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.